SHANGHAI SERUM BIO-TECHNOLOGY(688163.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
SHANGHAI SERUM BIO-TECHNOLOGY
688163.SH
Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China.
1.468 T
688163.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
BiotechnologyIndustry
Industry Ranking54/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE4.39%C
    • Profit Margin24.58%A
    • Gross Margin72.65%A
  • Growth ScoreC
    • Revenue YoY1.77%C
    • Net Profit YoY4.35%C
    • Total Assets YoY3.44%C
    • Net Assets YoY1.30%C
  • Cash ScoreC
    • Cash Flow Margin143.42%B
    • OCF YoY1.77%C
  • Operating ScoreD
    • Turnover0.17D
  • Debt ScoreA
    • Gearing Ratio3.56%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    SHANGHAI SERUM BIO-TECHNOLOGY released its performance for the first three quarters, with a net profit attributable to the parent company of 64.21 million yuan, a year-on-year increase of 2.01%

    Zhitong·
    SH
    688163
    +4.12%
    Zhitong·
    SH
    688163
    +4.12%

    Zhitong A-share lock-up release overview | September 11

    Zhitong·
    SZ
    002036
    -3.62%
    SZ
    301110
    -4.93%
    SH
    688163
    +4.12%
    Zhitong·
    SZ
    002036
    -3.62%
    SZ
    301110
    -4.93%
    SH
    688163
    +4.12%

    SHANGHAI SERUM BIO-TECHNOLOGY released its semi-annual performance, with a net profit attributable to the parent company of 32.98 million yuan, a year-on-year increase of 2.07%

    Zhitong·
    SH
    688163
    +4.12%
    Zhitong·
    SH
    688163
    +4.12%

    SHANGHAI SERUM BIO-TECHNOLOGY: Has not conducted research related to AIDS vaccines

    Zhitong·
    SH
    688163
    +4.12%
    Zhitong·
    SH
    688163
    +4.12%

    "Small and Beautiful" Stocks Exposed, 21 Stocks Listed

    Zhitong·
    SH
    688163
    +4.12%
    SH
    600883
    -0.22%
    SZ
    301167
    -1.21%
    Zhitong·
    SH
    688163
    +4.12%
    SH
    600883
    -0.22%
    SZ
    301167
    -1.21%
    © 2026 Longbridge｜Disclaimer